Bayer AG

Stocks

Real-time Estimate Tradegate 10:20:02 2026-08-26 EDT			5-day change	1st Jan Change
49.52 ^EUR	+0.53%		+0.96%	+33.69%

08-25	Bayer Group Receives Approval For Sevabertinib In Japan For HER2-Mutant Non-Small Cell Lung Cancer	CI
08-24	CAC 40 pauses ahead of Nvidia and Jackson Hole

Published on 04/24/2026 at 09:50 pm EDT - Modified on 04/28/2026 at 06:28 am EDT

S&P Capital IQ

Presenter Speech
Norbert Winkeljohann (Executives)

Ladies and gentlemen, as Chairman of the Supervisory Board of Bayer Aktiengesellschaft and thus Chairman of the meeting, I hereby open the company's

This article is reserved for our subscribers.

To unlock the article,
subscribe!

Unlimited browsing across the entire site

Access to all news and data

US, Europe, and Asia portfolios

Ad-free reading

Pro Tools : expert screeners, historical financials, PDF reports, investment themes, and earnings transcripts

08-25	Bayer Group Receives Approval For Sevabertinib In Japan For HER2-Mutant Non-Small Cell Lung Cancer	CI
08-24	CAC 40 pauses ahead of Nvidia and Jackson Hole
08-24	German Shares Slide Ahead of Anticipated US Sanctions on Iran	MT
08-24	Bayer's Hyrnuo approved in Japan for HER2-mutated non-small cell lung cancer
08-24	Bayer Wins Japanese Nod for Non-small Cell Lung Cancer Drug Hyrnuo	MT
08-24	Bayer Wins Japanese Nod for Hyrnuo in HER2 Unresectable Non-small Cell Lung Cancer	MT
08-21	MustGrow Biologics Secures First Milestone Payment from Bayer	MT
08-20	Cancer vaccines finally garner the spotlight
08-14	Bayer: Q2 surpassed expectations; now focus on deleveraging and operational delivery
08-14	Stuttgart Stock Exchange: Cisco Slips, Rheinmetall Reports Record Order Intake, Bayer Roundup	DP
08-14	Dax Companies Post Record Results and Cut Jobs	DP
08-12	Antitrust office: No general concerns about 50+1 rule	DP
08-11	Industry warns: Extreme low water pushes supply chains to the limit	RE
08-10	Bayer AG : Jefferies remains Neutral	ZD
08-07	Missouri Court Grants Delay for Bayer's Roundup Settlement Hearing	DJ